A gain-of-function mutation in STING has been identified as a gene responsible for a subpopulation of patients with SLE, and STING-dependent interferon-inducible genes correlated with disease activity (Kato et al., 2018; Konig et al., 2017). The gene discussed is STING1; the disease is systemic lupus erythematosus.